Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate

Progress in multiple sclerosis (MS) treatment now includes several approved first- and second-line therapies with others likely in the near future. Among new therapies, oral drugs represent important advances because they are easy to use; nevertheless, there are some associated side effects, which should be considered, to avoid potential complications. Dimethyl fumarate (DMF), an oral drug, modulates specific cells in the immune cascade and is...